|
TUBE1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.358600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.918200E-01 |
| Normal-vs-Stage2 |
3.780000E-01 |
| Normal-vs-Stage3 |
2.183800E-02 |
| Normal-vs-Stage4 |
6.122000E-01 |
| Stage1-vs-Stage2 |
3.933800E-01 |
| Stage1-vs-Stage3 |
1.696000E-02 |
| Stage1-vs-Stage4 |
7.442600E-01 |
| Stage2-vs-Stage3 |
6.291900E-02 |
| Stage2-vs-Stage4 |
8.039600E-01 |
| Stage3-vs-Stage4 |
7.667700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.373400E-01 |
| Normal-vs-AfricanAmerican |
7.094800E-01 |
| Normal-vs-Asian |
4.069600E-01 |
| Caucasian-vs-AfricanAmerican |
8.882200E-01 |
| Caucasian-vs-Asian |
4.483400E-01 |
| AfricanAmerican-vs-Asian |
4.688600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.571600E-01 |
| Normal-vs-Female |
9.320200E-01 |
| Male-vs-Female |
6.825200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.067600E-01 |
| Normal-vs-Extreme_Weight |
9.089600E-01 |
| Normal-vs-Obese |
6.259600E-01 |
| Normal-vs-Extreme_Obese |
5.161400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.830800E-01 |
| Normal_Weight-vs-Obese |
9.054600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.263200E-01 |
| Extreme_Weight-vs-Obese |
7.531000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.343800E-01 |
| Obese-vs-Extreme_Obese |
7.467200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.123400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.469000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.459400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.498500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.511800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.764400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.640100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.606800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.008100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.344400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.599600E-04 |
| Normal-VS-Type2 PRCC |
7.90640000000176E-05 |
| Normal-VS-KIRP CIMP |
3.915600E-01 |
| Normal-VS-Unclassified PRCC |
1.041650E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.86900050991312E-10 |
| Type1 PRCC-VS-KIRP CIMP |
7.973900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.970160E-04 |
| Type2 PRCC-VS-KIRP CIMP |
5.066400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.853550E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.029800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.848000E-01 |
| Normal-vs-N1 |
3.148200E-01 |
| Normal-vs-N2 |
5.810900E-04 |
| N0-vs-N1 |
8.295600E-01 |
| N0-vs-N2 |
2.297600E-01 |
| N1-vs-N2 |
2.049800E-01 |
|
|
